title: Special report: treatments for castration-resistant metastatic prostate cancer.
mesh_terms: D000730:Androstadienes / Q000627:therapeutic use; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D009919:Orchiectomy; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives / Q000627:therapeutic use; D010919:Placebos; D017430:Prostate-Specific Antigen / Q000187:drug effects; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000601:surgery; D016032:Randomized Controlled Trials as Topic; D043823:Taxoids / Q000627:therapeutic use; D014020:Tissue Extracts / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000730:Androstadienes; D010919:Placebos; D043823:Taxoids; D014020:Tissue Extracts; D010669:Phenylthiohydantoin; D017430:Prostate-Specific Antigen